Financial Enhancement Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $435K | Sell |
|
|||||
|
2025
Q2 | $465K | Buy |
|
|||||
|
2025
Q1 | $428K | Buy |
|
|||||
|
2024
Q4 | $424K | Buy |
|
|||||
|
2024
Q3 | $239K | Sell |
|
|||||
|
2024
Q2 | $337K | Buy |
|
|||||
|
2024
Q1 | $304K | Buy |
|
|||||
|
2023
Q4 | $271K | Hold |
|
|||||
|
2023
Q3 | $223K | Hold |
|
|||||
|
2023
Q2 | $225K | Hold |
|
|||||
|
2023
Q1 | $239K | Hold |
|
|||||
|
2022
Q4 | $212K | Hold |
|
|||||
|
2022
Q3 | $172K | Hold |
|
|||||
|
2022
Q2 | $166K | Hold |
|
|||||
|
2022
Q1 | $197K | Hold |
|
|||||
|
2021
Q4 | $189K | Hold |
|
|||||
|
2021
Q3 | $193K | Hold |
|
|||||
|
2021
Q2 | $190K | Hold |
|
|||||
|
2021
Q1 | $172K | Hold |
|
|||||
|
2020
Q4 | $160K | Hold |
|
|||||
|
2020
Q3 | $170K | Hold |
|
|||||
|
2020
Q2 | $156K | Hold |
|
|||||
|
2020
Q1 | $145K | Hold |
|
|||||
|
2019
Q4 | $201K | Hold |
|
|||||
|
2019
Q3 | $181K | Hold |
|
|||||
|
2019
Q2 | $191K | Buy |
|